Dr. Rachel L. Sturdivant, MD
- Medicare services, 2024
- 840
- Medicare patients, 2024
- 285
- Part D claims, 2024
- 1,011
- Publications
- 4
- MIPS score, 2024
- 79
- Practice address
- 171 Ashley Ave, Charleston, SC 29425
- Practice phone
- Call (843) 792-1414
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
MUSC University Hospital
Charleston, South Carolina
Find Dr. Sturdivant's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Rachel L. Sturdivant is a nephrologist in Charleston, South Carolina
Dr. Sturdivant practices at MUSC University Hospital in Charleston, South Carolina.
Dr. Sturdivant's NPI, 1225037765, was assigned on July 18, 2005. Dr. Sturdivant graduated from University of Alabama School of Medicine in 1998. Dr. Sturdivant holds South Carolina license 22000.
- NPI
- 1225037765NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3476546524
- NPI enumeration date
- July 18, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (843) 792-1414
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 54
- Medical school graduation
- 1998
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Rachel L. Sturdivant practices at MUSC University Hospital in Charleston, South Carolina
Dr. Sturdivant's primary practice is MUSC University Hospital, at 171 Ashley Ave, Charleston, SC 29425 in Charleston County. The practice phone is (843) 792-1414.
- MUSC University Hospital171 Ashley Ave, Charleston, SC 29425 · Charleston CountyPhone(843) 792-1414
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Rachel L. Sturdivant is affiliated with 9 sites of care and 1 medical group
Dr. Sturdivant's primary practice is MUSC University Hospital in Charleston, South Carolina. Dr. Sturdivant is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Sturdivant to 4 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Rachel L. Sturdivant's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sturdivant practices, 8 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| MUSC University Hospital | Available with a free account |
| +8 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Rachel L. Sturdivant is one of 156 nephrologists in South Carolina
Nephrology is Dr. Sturdivant's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Sturdivant is licensed in South Carolina.
Specialties and state licenses
- Nephrology, South CarolinaPrimary
Nephrologists near Dr. Sturdivant
Counts of nephrologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Rachel L. Sturdivant billed Medicare for 840 services in 2024
CMS data shows 840 Medicare services from Dr. Sturdivant across 11 procedure codes in 2024, for 285 Medicare patients. Medicare paid $68,846 for them.
Dr. Sturdivant's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 5592024: 5295%
- Other services
- 2023: 02024: 210
- Tests and treatments
- 2023: 2082024: 10151%
Where Dr. Sturdivant's Medicare services took place, 2024
- In an office51561%
- In a facility32539%
Dr. Sturdivant compared with the South Carolina median for nephrologists, 2024
- Dr. Sturdivant
- South Carolina median
- Medicare services
- 840vs 1,63949% below
- Medicare patients
- 285vs 41331% below
- Part D claims
- 786vs 7209% above
Medians across 155 nephrologists in South Carolina with Dmand AI profiles that report each measure.
Dr. Sturdivant's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Sturdivant?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sturdivant and other nephrologists in South Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Rachel L. Sturdivant treated 285 Medicare patients in 2024, average age 71
CMS counts 285 Medicare patients who saw Dr. Sturdivant in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 3.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Sturdivant's median patient age at 67, with 53% women.
Dr. Sturdivant's Medicare patients by age, 2024
Dr. Sturdivant's Medicare patients by sex, 2024
- Women15153%
- Men13447%
Chronic conditions among Dr. Sturdivant's Medicare patients, 2024
- Chronic kidney disease75%
- High blood pressure75%
- High cholesterol75%
- Diabetes52%
- Arthritis51%
- Heart failure46%
- Ischemic heart disease41%
- Atrial fibrillation38%
Share of Medicare patients with each condition. A patient can have several.
Dr. Sturdivant's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women53%
- Men47%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Rachel L. Sturdivant wrote 1,011 Medicare Part D claims in 2024
In 2024, Dr. Sturdivant wrote 1,011 Medicare Part D claims for 151 patients. 85% of them were for generic drugs. CMS names the drug for 786 of them, across 24 drugs with 11 or more claims each, at $145,065 in total drug cost. In 2023, CMS named 576 claims across 20 drugs.
Dr. Sturdivant's Part D claims by kind of drug, 2024
- Generic858 claims85%
- Brand-name153 claims15%
Dr. Sturdivant's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Sturdivant's Part D claims, 2024
- Antibiotics2%19 of 1,011 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5762024: 78636%
Drugs named by CMS: 24 in 2024, 20 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Rachel L. Sturdivant scored 79 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Sturdivant for performance year 2024, reported as part of a group. Dr. Sturdivant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sturdivant as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Sturdivant's MIPS scores, performance year 2024
- 79of 100Final score
- 62.4of 100Quality
- 99of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Rachel L. Sturdivant has 4 publications on record
Dmand AI links 4 papers to Dr. Sturdivant, published from 2011 to 2019. Dr. Sturdivant's most frequent co-authors are Karim Soliman, Michael E. Ullian, MD and Jean Aukerman Vickers, MD.
Dr. Sturdivant's most frequent co-authors
- Karim Soliman1 shared paper
- Michael E. Ullian, MD1 shared paper
- Jean Aukerman Vickers, MD1 shared paper
Recent publications by Dr. Sturdivant
Am J Med Sci
Adv Chronic Kidney Dis
See who Dr. Sturdivant researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sturdivant works with, so you can find a warm path to the right nephrologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Rachel L. Sturdivant received $731 in industry payments from 2019 to 2025
CMS Open Payments shows 7 general payments to Dr. Sturdivant from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Calliditas Therapeutics US Inc. paid the most, $249.
General payments to Dr. Sturdivant by program year, 2019 to 2025
Companies that paid Dr. Sturdivant the most, 2019 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Rachel L. Sturdivant graduated from University of Alabama School of Medicine
Dr. Sturdivant graduated from University of Alabama School of Medicine in 1998.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Rachel L. Sturdivant's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Rachel L. Sturdivant
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Rachel L. Sturdivant's NPI number?
Dr. Rachel L. Sturdivant's NPI number is 1225037765. It was assigned on July 18, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Rachel L. Sturdivant?
Dr. Rachel L. Sturdivant is a nephrologist in Charleston, South Carolina. The primary specialty in the NPI Registry is Nephrology Physician (taxonomy code 207RN0300X).
Where does Dr. Rachel L. Sturdivant practice?
Dr. Sturdivant practices at 171 Ashley Ave, Charleston, SC 29425. Dr. Sturdivant's primary practice is MUSC University Hospital in Charleston, South Carolina. Dmand AI also links Dr. Sturdivant to 4 hospitals, 2 dialysis centers and 1 group practice or clinic.
What is Dr. Rachel L. Sturdivant's office phone number?
The practice phone on file for Dr. Sturdivant is (843) 792-1414.
What is Dr. Rachel L. Sturdivant's medical license number?
Dr. Sturdivant holds South Carolina license 22000.
Which hospitals is Dr. Rachel L. Sturdivant affiliated with?
Dr. Sturdivant is affiliated with MUSC Health University Medical Center. Dmand AI links Dr. Sturdivant to 4 more hospitals.
What medical group is Dr. Rachel L. Sturdivant part of?
Dr. Sturdivant is linked to MUSC Health.
Does Dr. Rachel L. Sturdivant accept Medicare?
Yes. CMS data shows Dr. Sturdivant billed Medicare for 840 services in 2024, and Dr. Sturdivant accepts Medicare assignment.
Does Dr. Rachel L. Sturdivant offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Sturdivant as offering telehealth services.
What is Dr. Rachel L. Sturdivant's MIPS score?
Dr. Sturdivant's MIPS final score for performance year 2024 is 79 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Rachel L. Sturdivant see?
CMS counts 285 Medicare patients who saw Dr. Sturdivant in 2024, with an average age of 71.
What services does Dr. Rachel L. Sturdivant bill to Medicare?
In 2024, Dr. Sturdivant's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and hospital inpatient care (99233).
Where did Dr. Rachel L. Sturdivant go to medical school?
Dr. Sturdivant graduated from University of Alabama School of Medicine in 1998.
What drugs does Dr. Rachel L. Sturdivant prescribe most?
In 2024 Medicare Part D data, Dr. Sturdivant's most prescribed drugs by claims were Carvedilol, Amlodipine Besylate and Furosemide.
Has Dr. Rachel L. Sturdivant received payments from drug or device companies?
CMS Open Payments shows $731 in general payments to Dr. Sturdivant from 5 companies from 2019 to 2025. The largest total came from Calliditas Therapeutics US Inc.
How long has Dr. Rachel L. Sturdivant been practicing?
Dr. Sturdivant graduated from medical school in 1998, 28 years ago.
Does Dr. Rachel L. Sturdivant do research?
Dmand AI links 4 publications to Dr. Sturdivant, published from 2011 to 2019.
Who does Dr. Rachel L. Sturdivant publish with?
Dr. Sturdivant's most frequent co-authors are Karim Soliman (1 shared paper), Michael E. Ullian, MD (1 shared paper) and Jean Aukerman Vickers, MD (1 shared paper).
Selling to nephrology practices?
See nephrologists in South Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card